A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Margot Lazow, MD
Nationwide Children's Hospital
Study Chair - Maryam Fouladi, MD
Nationwide Children's Hospital
Study Chair - Patricia Baxter, MD
Baylor College of Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- the Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2018
- Primary completion
- 1 Mar 2024
- Completion
- 1 Mar 2029
- Last update posted
- 27 Mar 2026
- Registered enrollment
- 64
- Registry id
- NCT03605550
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.